Tianda Pharmaceuticals Limited is currently in a long term uptrend where the price is trading 22.6% above its 200 day moving average.
From a valuation standpoint, the stock is 99.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.1.
Tianda Pharmaceuticals Limited's total revenue sank by 6.7% to $123M since the same quarter in the previous year.
Its net income has increased by 18.3% to $786K since the same quarter in the previous year.
Finally, its free cash flow fell by 744.5% to $-31M since the same quarter in the previous year.
Based on the above factors, Tianda Pharmaceuticals Limited gets an overall score of 3/5.
